Meet 007: The cell with a license to kill cancer, created by an Israeli startup - Sponsored Content
Edity is programming the body’s own immune cells to carry therapeutics to places where treatment normally cannot reach
Stay updated with breaking news from Applied Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Edity is programming the body’s own immune cells to carry therapeutics to places where treatment normally cannot reach
CONVENING NOTICE This is the convening notice for the annual general meeting of shareholders of Centogene N.V. to be held on June 30, 2023 at 2.00 p.m. CEST at the offices of... | June 13, 2023
The study captured genetic variants at extremely low levels, and dozens of patients began new therapies as a result of the findings. Researchers from Children’s Hospital of Philadelphia (CHOP) recently discovered that extremely thorough “deep sequencing” of the genome in tissue samples and cell-f
Researchers from Children's Hospital of Philadelphia (CHOP) recently discovered that extremely thorough "deep sequencing" of the genome in tissue samples and cell-free DNA of patients with potentially life-threatening vascular anomalies captured several genetic variants related to disease that were not captured with conventional genetic sequencing methods.
Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The clinical outcomes of patients with active RA can be improved using anti-rheumatic medications, such as methotrexate (MTX).